biospace raises $18M to market musculoskeletal imaging system
biospace med has raised $18 million to expand the market for the EOS low-dose 2D/3D musculoskeletal imaging system in the U.S. and Europe.
According to the Paris-based company, investors include: Edmond de Rothschild Investment Partners, Crédit Agricole Private Equity, COFA Invest and UFG Private Equity of Paris; NBGI Ventures in London; and its latest investor, CDC Enterprises, on behalf of the strategic investment fund.
biospace said that radiation dose from EOS is 89 percent lower than standard CR x-ray and can produce 3D images of the human skeleton via reconstructive software that can generate 3D measurements.
Recently, EOS was installed at the two U.S. pediatric hospitals: the Rady Children’s Hospital in San Diego and the Wisconsin Children’s Hospital in Milwaukee.
According to the Paris-based company, investors include: Edmond de Rothschild Investment Partners, Crédit Agricole Private Equity, COFA Invest and UFG Private Equity of Paris; NBGI Ventures in London; and its latest investor, CDC Enterprises, on behalf of the strategic investment fund.
biospace said that radiation dose from EOS is 89 percent lower than standard CR x-ray and can produce 3D images of the human skeleton via reconstructive software that can generate 3D measurements.
Recently, EOS was installed at the two U.S. pediatric hospitals: the Rady Children’s Hospital in San Diego and the Wisconsin Children’s Hospital in Milwaukee.